Coronavirus News

How COVID-19 Pandemic Will Impact Reporter Gene Assay Market Business Opportunity, And Growth 2020-2029

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Reporter Gene Assay market.

Trusted Business Insights presents an updated and Latest Study on Reporter Gene Assay Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Reporter Gene Assay market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Reporter Gene Assay Market By Product (Assay Kits and Reagents), By End-User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutes, Hospital & Diagnostic Laboratories, and Contract Research Organizations), and By Application (Promoter Structural & Functional Analysis, Cell Signaling Pathways, Protein Interaction, and Gene Regulation)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020“2029

Abstract

A reporter gene is a gene type that investigators assigned to a regulatory sequence of another gene of importance in cell cultures, bacteria, plants, or animals. Specific genes are selected as reporters due to their specific traits. Reporter genes can also be employed to assay the expression of a gene that may produce proteins.

Rising funding for cell-based studies, growing inclination toward cell-based assays, rapidly rising applications of gene expression, increasing cancer cases, escalating demand for tailored medicines, and accelerating funding processes from government agencies will drive the reporter gene assay market globally. Increasing R&D activities and growing focus on technological innovation will generate more growth opportunities for the reporter gene assay market. However, the high research cost of cell biology, absence of skilled researchers, the dearth of latest healthcare infrastructure in developing nations, and the lack of awareness may restrict the reporter gene assay market growth globally.

The reporter gene assay market is split based on product, end-user, and application. By product, the reporter gene assay market includes assay kits and reagents. Assay kits are expected to show the highest CAGR over the estimated time period, owing to their recurrent use in studies related to gene expression and signaling pathway exploration along with benefits offered by assay kits above standalone reagents. The end-user segment includes biotechnology and pharmaceutical companies, research and academic institutes, hospital and diagnostic laboratories, and contract research organizations. Biotechnology and pharmaceutical companies dominated the market in 2018. The application segment includes promoter structural and functional analysis, cell signaling pathways, protein interaction, and gene regulation.

North America will lead the reporter gene assay market globally over the forecast time period. The region accounted for over 39% of the global market in 2018, due to the major funding for life sciences studies, growing applications of personalized medicines, rapidly rising cell-based investigation activities, availability of modern healthcare facilities, and the early acceptance of latest technologies. Europe holds the second spot of the global market, due to the presence of trained researchers, huge R&D funding by major companies, rising geriatric population, increasing chronic disorder occurrences, and positive reimbursement scenario. The Asia Pacific reporter gene assay market will grow rapidly over the estimated time period, owing to the rising chronic diseases incidences, growing interest in reporter gene assay, and increasing R&D related to gene therapy.

Some key players of the reporter gene assay market are Thermo Fisher Scientific, Merck, PerkinElmer, Promega Corporation, Abcam, Biotium, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Geno Technology, InvivoGen, Genecopoeia, PromoCell, Lonza Group, Cell Signaling Technology, and General Electric.

This report segments the global reporter gene assay market into:

Global Reporter Gene Assay Market: By Product

Assay Kits

Fluorescent Protein-linked
Luciferase Assay
Secreted Embryonic Alkaline Phosphatase
Beta-galactosidase Assay
Chloramphenicol Acetyltransferase Assay
Others

Reagents

Global Reporter Gene Assay Market: By End-User

Biotechnology and Pharmaceutical Companies
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Contract Research Organizations

Global Reporter Gene Assay Market: By Application

Promoter Structural and Functional Analysis
Cell Signaling Pathways
Protein Interaction
Gene Regulation

Global Reporter Gene Assay Market: By Region

North America

U.S.

Europe

UK
France
Germany

Asia Pacific

China
Japan
India

Latin America

Brazil

Middle East and Africa

Quick Read Table of Contents of this Report @ Reporter Gene Assay Market By Product (Assay Kits and Reagents), By End-User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutes, Hospital & Diagnostic Laboratories, and Contract Research Organizations), and By Application (Promoter Structural & Functional Analysis, Cell Signaling Pathways, Protein Interaction, and Gene Regulation)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020“2029

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580